Latest news, press releases, and SEC filings for Nanobiotix SA (NBTX) https://caymanjournal.com/stock/NBTX en-us Copyright 2026, Cayman Journal editorial@caymanjournal.com (Editorial Team) webmaster@caymanjournal.com (Web Master) Mon, 27 Apr 2026 20:32:26 GMT 60 https://caymanjournal.com/logo.png https://caymanjournal.com 144 144 # 📝 What This Document Is 📰 This document is a Form 6-K press release (Exhibit 99.1) announcing that Nanobiotix presented new, highly technical preclinical data at the 2026 Annual Meeting of the American Association for Cancer Research (AACR). Essentially, the company is providing an early look at https://caymanjournal.com/stock/NBTX/sec-filing/0001171843-26-002539 https://caymanjournal.com/stock/NBTX/sec-filing/0001171843-26-002539 Mon, 20 Apr 2026 00:00:00 GMT SEC Filing # 🧾 What This Document Is This is a standard regulatory filing from **Nanobiotix (NBTX)**. It’s not an earnings report or a press release about a big discovery—it’s a required, routine update to inform the market about the company's **share structure and voting power** as of March 31, 2026. 👉 ** https://caymanjournal.com/stock/NBTX/sec-filing/0001171843-26-002299 https://caymanjournal.com/stock/NBTX/sec-filing/0001171843-26-002299 Tue, 07 Apr 2026 00:00:00 GMT SEC Filing # 🧾 What This Document Is This is a **6-K filing** from Nanobiotix, which is a current report foreign companies file with the SEC to share major news. It contains a press release that serves as a comprehensive business update and a report of their full financial results for 2025. Think of it as the https://caymanjournal.com/stock/NBTX/sec-filing/0001171843-26-002097 https://caymanjournal.com/stock/NBTX/sec-filing/0001171843-26-002097 Tue, 31 Mar 2026 00:00:00 GMT SEC Filing # 🧾 What This Document Is This is a **6-K report**, which is a form foreign companies like Nanobiotix (based in France) use to tell the U.S. market about important events. This one is essentially a press release sharing the first clinical trial results for one of their key drugs, presented at a ma https://caymanjournal.com/stock/NBTX/sec-filing/0001171843-26-001999 https://caymanjournal.com/stock/NBTX/sec-filing/0001171843-26-001999 Mon, 30 Mar 2026 00:00:00 GMT SEC Filing